![Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations | Semantic Scholar Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2019eac8fb8a0ac9ae460c5e7711983b957e1a3d/2-Table1-1.png)
Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations | Semantic Scholar
![PDF) Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy PDF) Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy](https://i1.rgstatic.net/publication/310222748_Establishing_the_heparin_therapeutic_range_using_aPTT_and_anti-Xa_measurements_for_monitoring_unfractionated_heparin_therapy/links/5a0b9119aca2721a23f9e173/largepreview.png)
PDF) Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy
![The effect of anti-Xa monitoring on the safety and efficacy of low-molecular-weight heparin anticoagulation therapy: A systematic review and meta-analysis.,Journal of Clinical Pharmacy and Therapeutics - X-MOL The effect of anti-Xa monitoring on the safety and efficacy of low-molecular-weight heparin anticoagulation therapy: A systematic review and meta-analysis.,Journal of Clinical Pharmacy and Therapeutics - X-MOL](https://xpic.x-mol.com/20200707%2F10.1111_jcpt.13169.jpg)
The effect of anti-Xa monitoring on the safety and efficacy of low-molecular-weight heparin anticoagulation therapy: A systematic review and meta-analysis.,Journal of Clinical Pharmacy and Therapeutics - X-MOL
![Effects of Pre-analytical Variables on the anti-Xa Chromogenic Assay when Monitoring Unfractionated Heparin and Low Molecular Weight Heparin Anticoagulation. - ppt download Effects of Pre-analytical Variables on the anti-Xa Chromogenic Assay when Monitoring Unfractionated Heparin and Low Molecular Weight Heparin Anticoagulation. - ppt download](https://images.slideplayer.com/25/8040193/slides/slide_3.jpg)
Effects of Pre-analytical Variables on the anti-Xa Chromogenic Assay when Monitoring Unfractionated Heparin and Low Molecular Weight Heparin Anticoagulation. - ppt download
![Anti-Factor Xa–Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort - The Journal of Pediatrics Anti-Factor Xa–Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort - The Journal of Pediatrics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4791b074-9ca3-446e-9aa6-bda5b5bb59aa/gr1.jpg)
Anti-Factor Xa–Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort - The Journal of Pediatrics
![Evaluation of a heparin monitoring protocol for extracorporeal membrane oxygenation and review of the literature - Colman - Journal of Thoracic Disease Evaluation of a heparin monitoring protocol for extracorporeal membrane oxygenation and review of the literature - Colman - Journal of Thoracic Disease](https://cdn.amegroups.cn/journals/pbpc/files/journals/2/articles/31125/public/31125-PB4-9129-R1.png)
Evaluation of a heparin monitoring protocol for extracorporeal membrane oxygenation and review of the literature - Colman - Journal of Thoracic Disease
![How anticoags work, and what that means for labs CAP Today January 2013 Feature Story When to monitor and how? These questions were simpler when the list of anticoagulants patients were given was two or three deep—warfarin and unfractionated ... How anticoags work, and what that means for labs CAP Today January 2013 Feature Story When to monitor and how? These questions were simpler when the list of anticoagulants patients were given was two or three deep—warfarin and unfractionated ...](http://www.captodayonline.com/Archives/0113/0113ga_how_anticoags_work_table.jpg)
How anticoags work, and what that means for labs CAP Today January 2013 Feature Story When to monitor and how? These questions were simpler when the list of anticoagulants patients were given was two or three deep—warfarin and unfractionated ...
![PDF) The use of the activated clotting time for monitoring heparin therapy in critically ill patients PDF) The use of the activated clotting time for monitoring heparin therapy in critically ill patients](https://i1.rgstatic.net/publication/10892780_The_use_of_the_activated_clotting_time_for_monitoring_heparin_therapy_in_critically_ill_patients/links/5725c84f08ae262228ae0240/largepreview.png)